[ad_1]
RIO – The biggest impact of the suspension of the AstraZeneca / University of Oxford vaccine tests, after detecting a case of “severe reaction”, will be the increase in time until the approval of immunizations against Covid-19. The World Health Organization (WHO) acknowledged yesterday that it is unlikely that there will be a proven safe and efficient vaccine for widespread use before 2022. The time for science is not the time for political pressure to approve a vaccine scientists emphasize.
Analytical: What You Need to Know After Your Covid-19 Vaccine Test Cessation
Studies of the vaccine are suspended throughout the world, including in Brazil. In Brazil, it is tested in Rio de Janeiro and Bahia by Rede D’Or and in São Paulo by Unifesp. The Ministry of Health signed an agreement with AstraZeneca for Fiocruz to produce the immunizer. On Tuesday, Acting Health Minister Eduardo Pazuello even said vaccination would start in January.
AstraZeneca has given no deadlines to resume testing. But this type of evaluation usually takes months, said UFRJ virologist Davis Ferreira. However, he notes that the case in no way invalidates this and the other vaccines. The tests evaluate whether a vaccine, any of the 239 in development in the world, is safe and effective.
READ MORE: See the full report here.
